| Literature DB >> 25551600 |
Yuan Quan1, Bin Li2, You-Min Sun3, Hong-Yu Zhang4.
Abstract
Natural medicines have attracted wide attention in recent years. It is of great significance to clarify the pharmacological mechanisms of natural medicines. In prior studies, we established a method for elucidating pharmacological mechanisms of natural products contained in connectivity map (cMap), in terms of module profiles of gene expression in chemical treatments. In this study, we explore whether this methodology is applicable to dissecting the pharmacological mechanisms of natural medicines beyond the agents contained in cMap. First, the gene expression profiles of curcumin (a typical isolated natural medicine) and Si-Wu-Tang (a classic traditional Chinese medicine formula) treatments were merged with those of cMap-derived 1309 agents, respectively. Then, a biclustering analysis was performed using FABIA method to identify gene modules. The biological functions of gene modules provide preliminary insights into pharmacological mechanisms of both natural medicines. The module profile can be characterized by a binary vector, which allowed us to compare the expression profiles of natural medicines with those of cMap-derived agents. Accordingly, we predicted a series of pharmacological effects for curcumin and Si-Wu-Tang by the indications of cMap-covered drugs. Most predictions were supported by experimental observations, suggesting the potential use of this method in natural medicine dissection.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25551600 PMCID: PMC4307259 DOI: 10.3390/ijms16010510
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The enriched GO function of module 27 of cMap-Si-Wu-Tang dataset, with p-values adjusted by False Discovery Rate calculation using Benjamini-Hochberg method [24].
Figure 2The enriched KEGG function of module 27 of cMap-Si-Wu-Tang dataset, with p-values adjusted by False Discovery Rate calculation using Benjamini-Hochberg method [24].
Figure 3Electron affinity (EA) and energy level of the lowest unoccupied molecular orbital (ELUMO) of tanshinones and curcumin calculated at B3LYP/6-31+G(d) level. The data of tanshinones are from [20].
Figure 4Cumulative frequency (f(x)) of pairwise Tanimoto coefficients for cMap-curcumin dataset.
Predicted similar drugs to curcumin.
| Drugs | Tanimoto Coefficients | Therapeutic Uses |
|---|---|---|
| Esculin a | 0.48 | Anti-inflammatory |
| Clobetasol b | 0.42 | Anti-inflammatory Agents, Corticosteroids, Topical, Glucocorticoids |
| Iodixanol b | 0.41 | Contrast Media |
| Sulpiride b | 0.38 | Antidepressants, Antidepressive Agents, Second-generation, Antipsychotic Agents, Antipsychotics |
| Amantadine b | 0.38 | Analgesics, Non-narcotic, Antiparkinson Agents, Anti-viral Agents, Dopamine Agents |
| Oxolinic acid a | 0.38 | Anti-bacterial |
| Lomefloxacin b | 0.38 | Anti-infective Agents, Anti-infective Agents, Urinary, Antitubercular Agents, Photosensitizing Agents |
a The Therapeutic Uses of drugs from ChemBank [25]; b The Therapeutic Uses of drugs from DrugBank [26].
Figure 5Cumulative frequency (f(x)) of pairwise Tanimoto coefficients for cMap-Si-Wu-Tang dataset.
Predicted similar drugs to Si-Wu-Tang.
| Drugs | Tanimoto Coefficients | Therapeutic Uses |
|---|---|---|
| Clioquinol a | 0.41 | Anti-infective Agent |
| Carmustine b | 0.41 | Antineoplastic Agents, Antineoplastic Agents, Alkylating |
| Celastrol a | 0.40 | Anti-bacterial, Anti-proliferative |
| Spiperone a | 0.38 | Tranquilizer |
| Mometasone b | 0.38 | Anti-allergic Agents, Anti-inflammatory Agents |
| Lomustine b | 0.37 | Antineoplastic Agents, Antineoplastic Agents, Alkylating |
| Withaferin A b | 0.36 | Calcium Channel Blockers, Dihydropyridines, Tocolytic Agents, Vasodilator Agents |
| Nifedipine b | 0.36 | Vasodilator Agents |
| Diethylstilbestrol b | 0.36 | Antineoplastic Agents, Hormonal, Carcinogens, Estrogens, Non-steroidal |
| Chlorzoxazone b | 0.36 | Muscle Relaxants, Central |
a The Therapeutic Uses of drugs from ChemBank [25]; b The Therapeutic Uses of drugs from DrugBank [26].